Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    Conference Program for 2022 the World Conference on Lung Cancer

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2137

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    WS04 - IASLC/IMIG Workshop - The Future of Mesothelioma Treatment

    • 08:00 - 11:00
    • 8/06/2022
    • Location: Lehar 4
    • Not for CME Credit
    • Type: Workshop
    • Track: N/A
    • +

      WS04.15 - Panel - Everything You Wanted to Know About Mesothelioma but Were Afraid to Ask

      11:00 - 11:00  |  Presenter: Andreas Rimner

      • Abstract

      Loading...

  • +

    IBS06 - Which Therapy for Which MPM Patient? (Ticketed Session) (In-person Access Only)

    • 07:30 - 08:15
    • 8/07/2022
    • Location: Lehar 4
    • IASLC CME Accredited
    • Type: Interactive Breakfast Session
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies
    • +

      IBS06.03 - Local Treatments for Meso - Radiotherapy

      07:45 - 08:00  |  Presenter: Andreas Rimner

      • Abstract

      Loading...

  • +

    EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
    • +

      EP05.01-014 - Circulating Tumor DNA to Identify Genomic Biomarkers of Radiation Sensitivity in Locally Advanced Non-Small Cell Lung Cancer

      Presenter: Emily Lebow

      • Abstract

      Loading...

    • +

      EP05.01-025 - Planned Interim Analysis of a Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Lung Cancer

      Presenter: Andreas Rimner

      • Abstract

      Loading...

  • +

    EP07.01 - Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Mesothelioma, Thymoma, and Other Thoracic Malignancies - Clinical
    • +

      EP07.01-018 - Phase III Randomized Trial on Surgery, Chemo and Pleural Radiation (IMPRINT) for Resectable Pleural Mesothelioma (NRG LU-006)

      Presenter: Andreas Rimner

      • Abstract

      Loading...

  • +

    P1.05 - Early Stage Non-small Cell - Biomarkers

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Early Stage Non-small Cell - Biomarkers
    • +

      P1.05-02 - Mutations in CREBBP are Associated with Local Failure after Lung Stereotactic Body Radiation Therapy

      Presenter: Victor Chan Ng

      • Abstract

      Loading...